Skip to content

GREENVEIL

  • pharma

Sodium phosphate, dibasic

CAS 10140-65-5

Concern score

Not assessed — no hazard data yet.

Sodium phosphate, dibasic in plain language

What it is

Also known as Disodium phosphate hydrate · Sodium hydrogen phosphate--water (2/1/1) · sodium phosphate dibasic

What it does

We don't have a plain-language description for Sodium phosphate, dibasic yet.

Is it a concern?
We haven't assessed a concern score for this ingredient yet.

What we know about this ingredient

EPA DSSTox provides the canonical identifier, structure, and synonym profile for this chemical.

Regulation

No restrictions found. Sodium phosphate, dibasic appears in these published regulatory listings.

  • In marketed US drugs
  • Inactive ingredient in US drugs
  • USFDAinactive ingredient database14 entries — 7 administration routes
    • Route: INTRADERMAL; Dosage form: INJECTION; Potency: 0.2 %w/vSource →
    • Route: INTRAMUSCULAR; Dosage form: INJECTION; Potency: 40 mgSource →
    • Route: INTRAMUSCULAR; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 40 mgSource →
    • Route: INTRAVENOUS; Dosage form: INJECTION; Potency: 200 mgSource →
    • Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 40 mgSource →
    • Route: OPHTHALMIC; Dosage form: SUSPENSION; Potency: 0.43 %w/wSource →
    • Route: ORAL; Dosage form: CONCENTRATE; Potency: 17 mg/5mlSource →
    • Route: ORAL; Dosage form: FILM, SOLUBLE; Maximum daily exposure: 9 mgSource →
    • Route: ORAL; Dosage form: SOLUTION; Potency: 40 mg/1mlSource →
    • Route: ORAL; Dosage form: SYRUP; Maximum daily exposure: 70 mgSource →
    • Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 143 mgSource →
    • Route: SUBCUTANEOUS; Dosage form: INJECTION; Maximum daily exposure: 14 mgSource →
    • Route: SUBCUTANEOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: 2.98 mgSource →
    • Route: TOPICAL; Dosage form: CREAM; Potency: 0.1 %w/wSource →
  • USFDAmarketed drug occurrenceFDA NDC lists this ingredient in 17 active drug products and 18 total products.
    • FDA NDC lists this ingredient in 17 active drug products and 18 total products.Source →
  • USFDAlisted in openFDA substanceopenFDA substance registry classifies this ingredient as mixture.
    • openFDA substance registry classifies this ingredient as mixture.Source →

Evidence & sources

No graded research studies for Sodium phosphate, dibasic yet. This record is compiled from the published data sources below — registries and regulatory listings, not study findings.

5 data sources

Where this comes from

  • EPA DSSTox Identifiers

    chemistry · updated 2025-12-29

    Open →

  • FDA Inactive Ingredient Database

    regulatory · updated 2026-01-09

    Open →

  • FDA National Drug Code Directory

    regulatory · updated 2026-12-31

    Open →

  • FDA GSRS UNII

    registry · updated 2026-02-26

    Open →

  • openFDA Substance

    registry · updated 2026-05-24

    Open →

Suitability

Context-specific fit derived from published classifications and the current ingredient evidence profile.

Fragrance avoidance

Nothing to weigh for this context yet.

No signal in this context

We have no published hazard signal for this ingredient, so we cannot say how it behaves in this context — that is missing evidence, not a clean result.

Where it has been recorded

How often FDA National Drug Code directory has listed Sodium phosphate, dibasic in a product composition. These are source records, not Greenveil catalog products.

Source records

18

See products using Sodium phosphate, dibasic →

Catalog

Found in these products

Their ingredient lists include Sodium phosphate, dibasic; each product's own rating depends on its whole formula, so it is shown on the product page, not here.

See all 19 →Find products without it →